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INTRODUCTION
An adverse drug reaction is defined by the World
Health Organisation (WHO) as a response to a
medicine which is noxious and unintended and which
occurs at doses normally used in man.1 Cutaneous
adverse drug reactions (CADRs) are a most
commonly reported type of adverse drug reaction
(ADR).2 There is limited information about ADRs in
children from developing countries especially from sub
Saharan Africa.3,4 Angioedema, first described in 1586,5
is usually defined by pronounced swelling of the deep
dermis, subcutaneous or submucosal tissue, or mucous
membranes as a result of vascular leakage.6 Other
terms, such as giant urticaria,7 Quincke edema,8 and
angioneurotic edema,9  have also been used in the past
to describe this condition. Clinically, it is usually non-
pitting and non-pruritic. Involved skin often shows
no change in colour or may be slightly erythematous.
It is most commonly observed affecting the lips and
eyes (periorbital). Other commonly involved areas
include the face, hands, feet, and genitalia. Angioedema
is classified as either hereditary or acquired. Acquired
angioedema can be immunologic, non-immunologic,
or idiopathic.10 Allergic angioedema is the commonest
type. Drugs that have been reported as being involved
in ADRs include: antibiotics,11,12 non-steroidal anti-
inf lammatory drugs. 13,14 We report a case of
angioedema following administration of mebendazole,
cotrimoxazole and leaf  extracts.
CASE REPORT
A 12 year old boy who presented at the Paediatric
Nephrology Clinic with a day history of  periorbital
swelling, skin rash, pruritus and low grade fever. A
day prior to the onset of these symptoms, he had
been given mebendazole tablets as anti-helminthic –
300mg in the morning and in the evening. The
following morning, he was noticed to have peri-orbital
swelling and subsequently facial swelling. He was also
noticed to have pruritic rash about the same time. This
involved the face, trunk and upper limbs. The upper
part of  the child’s body was also noticed to have been
bigger than normal. There was no preceding insect
bite, ingestion of a new type of food or contact with
latex. There was also no family history of such ailment.
This was the first episode of body swelling and first
episode of Mebendazole intake. He had been given
oral cotrimoxazole, vitamin c and bitter leaf extracts
before presentation in the hospital.
Physical examination revealed that he had peri-orbital
oedema with sub-mental fullness and papular skin rash
involving the face, trunk and upper limbs. He was not
dyspnoeic and had respiratory rate of 16/minute. His
pulses were of  normal volume and his heart rate and
blood pressure were 80/min and 100/60mmHg
respectively. The heart sounds were heart sounds 1
and 2, and were normal. He did not have any other
significant abnormalities in other systems. Investigations
done included urinalysis, blood electrolytes and urea,
full blood count, and fasting lipids profile. All these
were within normal ranges.
A diagnosis of Angioneurotic Oedema was made.
Other differential diagnosis considered were Acute
Glomerulonephritis and Nephrotic syndrome. He was
placed on steroids – Oral Prednisolone 60mg daily
for 3 days. By the second day on admission, oedema
was regressing and by the 3rd day it had resolved
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completely as well as the rash. The parents pressed for
discharge and were allowed home on the 4th day on
admission. He was lost to follow up.
DISCUSSION
Mebendazole is synthetic broad spectrum anti-
helminthic which through microtubular destruction kills
helminths by inhibiting glucose uptake into susceptible
parasites.15 The dose is 100mg twice daily for three
consecutive days.16 Common side effects include:
nausea, vomiting while rare side effects include: rash,
alopecia, urticaria and angioedema. Adverse effects
appear to occur more frequently when higher doses
are used.17
A compiled information from Food and Drug
administration (FDA) and Facts Med users submissions
between January 2004 and October 2012 showed that
two individuals taking mebendazole reported angio-
edema to the FDA while a total of  152 mebendazole
drug adverse event reaction reports were made with
the FDA during this time period.18
Trimethoprim/Sulfamethoxazole (TMP/SMX) also
known as co-trimoxazole is an antibiotic used for
urinary tract infections, MRSA skin infections, travelers’
diarrhoea, respiratory tract infections and cholera
among others.19 It works by stopping the metabolism
of  folate. Due to it’s high incidence of  adverse effects,
including allergic responses, its use has been restricted
in many countries to very specific circumstances where
its improved efficacy has been demonstrated.20
A clinical study of cutaneous drug eruptions in 200
patients in India aged between 1 year to 80 years in the
year 2008 revealed that co-trimoxazole was the most
common cause of  drug eruptions.21
Traditional medications are used mostly in cases of
fever, convulsion and rashes in children just to mention
a few. There is paucity of  studies on children who
developed adverse drug reactions following its use. In
a retrospective audit of reports of ADRs received by
the pharmacovigilance unit (PV) in children aged less
than 18 years in the Ahmadu Bello University Teaching
Hospital, Zaria (ABUTH) from 2008 to 2012, only 2
children were documented to have had ADRs
following traditional medicine use.22
Understanding the various possible causes is the first
step in assessing angioedema. Allergic and drug –
induced angioedema responds to removal of cause.23
Investigations that can be done in the case of
angioedema include: Complete blood count,
electrolytes, renal function and liver enzymes. Also mast
cell tryptase levels may be elevated if the attack was
due to acute allergy (anaphylactic reaction).
The immediate management of systemic reaction
focuses on the treatment of anaphylaxis, for which
administration of subcutaneous epinephrine (0.3ml of
a 1:1,000 dilution) is the treatment of choice.24,25 An
antihistamine, such as diphenhydramine (Benadryl) or
hydroxyzine (Atarax, Vistaryl) may be given after
epinephrine has been administered to reduce pruritus
and inflammation.25 When the conventional H1 and
H2 antihistamines failed, other drugs like Nifedipine is
used as an adjunct to antihistamines. Some authors
suggest the use of  corticosteroids depending on clinical
presentation24 while others mention corticosteroid
therapy using intravenous dexamethasone sodium
phosphate or hydrocortisone which remains the main
treatment for angioedema.
CONCLUSION
Adverse drug reactions are global problems affecting
children in both developing and developed countries.
A higher level of clinical suspicion and vigilance, good
knowledge of the predisposing factors, and proper
monitoring of at-risk drugs in at-risk patients may help
prevent ADRs thus reducing its global incidence.
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